Trial Profile
A drug utilisation study (DUS) of the use of oral fidaxomicin in the routine clinical setting (2819-CL-2002) ("Anemone")
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2018
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- Acronyms Anemone
- Sponsors Astellas Pharma
- 11 Aug 2018 Status changed from recruiting to completed, as per the results published in the European Journal of Clinical Microbiology and Infectious Diseases
- 11 Aug 2018 Results (n=576) published in the European Journal of Clinical Microbiology and Infectious Diseases
- 11 Mar 2016 New trial record